Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) has earned an average recommendation of “Hold” from the five ratings firms that are currently covering the firm, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $12.00.
A number of research analysts have recently weighed in on VMD shares. Wall Street Zen upgraded Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 7th. Freedom Capital lowered shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 5th. Freedom Broker decreased their price objective on shares of Viemed Healthcare from $11.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, November 9th. Barrington Research started coverage on shares of Viemed Healthcare in a research note on Monday, August 24th. They issued an “outperform” rating and a $14.00 price objective on the stock. Finally, Weiss Ratings downgraded shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, August 17th.
Get Our Latest Stock Analysis on VMD
Institutional Investors Weigh In On Viemed Healthcare
Several hedge funds have recently made changes to their positions in the business. Renaissance Technologies LLC grew its holdings in Viemed Healthcare by 0.3% in the 1st quarter. Renaissance Technologies LLC now owns 442,200 shares of the company’s stock valued at $4,073,000 after buying an additional 1,400 shares during the last quarter. State of Alaska Department of Revenue increased its position in Viemed Healthcare by 49.8% in the 3rd quarter. State of Alaska Department of Revenue now owns 5,145 shares of the company’s stock worth $46,000 after buying an additional 1,711 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Viemed Healthcare by 2.2% during the first quarter. Bank of New York Mellon Corp now owns 81,326 shares of the company’s stock worth $749,000 after buying an additional 1,773 shares during the last quarter. Signaturefd LLC lifted its holdings in shares of Viemed Healthcare by 64.0% during the third quarter. Signaturefd LLC now owns 4,939 shares of the company’s stock worth $45,000 after buying an additional 1,927 shares during the last quarter. Finally, Covestor Ltd acquired a new position in shares of Viemed Healthcare during the third quarter worth approximately $28,000. Institutional investors and hedge funds own 74.24% of the company’s stock.
Viemed Healthcare Stock Performance
Shares of VMD stock opened at $9.17 on Monday. The company has a market capitalization of $347.48 million, a P/E ratio of 24.13, a price-to-earnings-growth ratio of 2.25 and a beta of 1.05. The company has a current ratio of 1.25, a quick ratio of 1.16 and a debt-to-equity ratio of 0.05. The business’s 50 day moving average is $9.28 and its two-hundred day moving average is $9.64. Viemed Healthcare has a twelve month low of $6.18 and a twelve month high of $12.61.
Viemed Healthcare (NASDAQ:VMD – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Viemed Healthcare had a net margin of 5.03% and a return on equity of 10.64%. The business had revenue of $80.67 million during the quarter, compared to analyst estimates of $80.78 million. Equities analysts forecast that Viemed Healthcare will post 0.41 EPS for the current year.
Viemed Healthcare Company Profile
Viemed Healthcare, Inc. provides in-home respiratory care and related medical equipment to patients with chronic respiratory conditions. Its services are designed to help patients receive respiratory support at home rather than in a hospital or other care facility. The company supplies equipment such as non-invasive ventilators, oxygen systems and airway-clearance devices. Viemed’s respiratory therapists also help patients and caregivers use the equipment and provide ongoing clinical support. Based in the United States, Viemed serves patients in multiple states.
Further Reading
- Five stocks we like better than Viemed Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
